Repurposing drugs in oncology (ReDO) - Chloroquine and hydroxychloroquine as anti-cancer agents

ecancermedicalscience

Volumn 11, Issue , 2017, Pages

  Verbaanderd, Ciska ^a,b,c   Maes, Hannelore ^b   Schaaf, Marco B ^b   Sukhatme, Vikas P ^d,e,f   Pantziarka, Pan ^a,g   Sukhatme, Vidula ^d   Agostinis, Patrizia ^b   Bouche, Gauthier ^a  

^a Anticancer Fund   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^d GlobalCures Inc   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g George Pantziarka TP53 Trust   (United Kingdom)

Author keywords

Anti malarial agents; Antineoplastic agents; Chloroquine (CQ); Drug repositioning; Hydroxychloroquine (HCQ); Neoplasms; Repurposing Drugs in Oncology (ReDO) project

Indexed keywords

4 AMINOQUINOLINE; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BORTEZOMIB; CARBOPLATIN; CHEMOKINE RECEPTOR CXCR4; CHLOROQUINE; CISPLATIN; CURCUMIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; EVEROLIMUS; FLUOROURACIL; GEFITINIB; GEMCITABINE; HYDROXYCHLOROQUINE; OXALIPLATIN; PANOBINOSTAT; PROPYLTHIOURACIL; PROTEIN P53; RAPAMYCIN; STROMAL CELL DERIVED FACTOR 1; TEMOZOLOMIDE; TEMSIROLIMUS; TOLL LIKE RECEPTOR 9; UNINDEXED DRUG; VORINOSTAT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER THERAPY; DRESS SYNDROME; DRUG ACTIVITY; DRUG REPOSITIONING; HUMAN; IMMUNE SYSTEM; LIVER AMEBIASIS; LIVER TUMOR; LUPUS VULGARIS; MALARIA; MELANOMA; NEUROBLASTOMA; NONHUMAN; ONCOLOGY; PHARMACOKINETIC PARAMETERS; PLASMACYTOMA; RETINOPATHY; RHEUMATOID ARTHRITIS; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 85034808566     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2017.781     Document Type: Article

References (194)

1. Ben-Zvi I et al (2012) Hydroxychloroquine: from malaria to autoimmunity Clinical Reviews in Allergy and Immunology 42 145-153 https://doi.org/10.1007/s12016-010-8243-x
2. Thomé R et al (2013) Chloroquine: modes of action of an undervalued drug Immunology Letters 153(1-2) 50-57 https://doi. org/10.1016/j.imlet.2013.07.004 PMID: 23891850
3. Anon (n.d.) Avloclor tablets - summary of product characteristics (SPC) - (eMC) [online] Available from: https://www.medicines. org.uk/emc/medicine/2272 (Accessed 15 January 2016)
4. Anon (n.d.) Plaquenil 200mg film-coated tablets - summary of product characteristics (SPC) - (eMC) [online] Available from: https://www.medicines.org.uk/emc/medicine/6977 (Accessed 15 January 2016)
5. Lee S-J et al (2011) The role of antimalarial agents in the treatment of SLE and lupus nephritis Nature Reviews Nephrology 7(12) 718-729 https://doi.org/10.1038/nrneph.2011.150 PMID: 22009248
6. Dubois EL (1978) Antimalarials in the management of discoid and systemic lupus erythematosus Seminars in Arthritis and Rheumatism 8(1) 33-51 https://doi.org/10.1016/0049-0172(78)90033-1 PMID: 358397
7. Olson NY and Lindsley CB (1989) Adjunctive use of hydroxychloroquine in childhood dermatomyositis The Journal of Rheumatology 16(12) 1545-1547 PMID: 2483176
8. Costedoat-Chalumeau N et al (2007) Cardiomyopathy related to antimalarial therapy with illustrative case report Cardiology 107(2) 73-80 https://doi.org/10.1159/000094079
9. Browning DJ (2014) Pharmacology of chloroquine and hydroxychloroquine Hydroxychloroquine and Chloroquine Retinopathy 35-63 https://doi.org/10.1007/978-1-4939-0597-3-2
10. Costedoat-Chalumeau N et al (2015) A critical review of the effects of hydroxychloroquine and chloroquine on the eye Clinical Reviews in Allergy & Immunology 49(3) 317-326 https://doi.org/10.1007/s12016-015-8469-8
11. Nagaratnam N et al (1978) Aplasia and leukaemia following chloroquine therapy Postgraduate Medical Journal 54(628) 108-112 https://doi.org/10.1136/pgmj.54.628.108 PMID: 273209 PMCID: 2425073
12. Goyal V and Bordia A (1995) The hypoglycemic effect of chloroquine The Journal of the Association of Physicians of India 43(1) 17-18 PMID: 9282631
13. Marmor MF et al (2016) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision) Ophthalmology 123(6) 1386-1394 https://doi.org/10.1016/j.ophtha.2016.01.058 PMID: 26992838
14. Warhurst DC et al (2003) Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant plasmodium falciparum, in agreement with its physicochemical properties The Journal of Antimicrobial Chemotherapy 52(2) 188-193 https:// doi.org/10.1093/jac/dkg319 PMID: 12837731
15. Day RO et al (eds.) (2005) Antirheumatic Therapy: Actions and Outcomes Birkhäuser: Basel
16. Jutten B et al (2013) EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival Radiotherapy and Oncology 108(3) 479-483 https://doi.org/10.1016/j.radonc.2013.06.033 PMID: 23891088
17. Kim EL et al (2010) Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells Neuro-Oncology 12(4) 389-400 https://doi.org/10.1093/neuonc/nop046 PMID: 20308316 PMCID: 2940600
18. Song YJ et al (2013) Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrientdeprived tumor microenvironment Cancer Letters 339(1) 70-81 https://doi.org/10.1016/j.canlet.2013.07.021 PMID: 23879969
19. Hu T et al (2016) Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo Oncology Reports 35(1) 43-49 https://doi.org/10.3892/or.2015.4380 PMCID: 4699623
20. Lakhter AJ et al (2013) Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation The Journal of Investigative Dermatology 133(9) 2247-2254 https://doi.org/10.1038/jid.2013.56 PMID: 23370537 PMCID: 3675185
21. Zheng Y et al (2009) Chloroquine inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis Cancer Investigation 27(3) 286-292 https://doi.org/10.1080/07357900802427927 PMID: 19194831
22. Jiang PD et al (2010) Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer Biomedicine and Pharmacotherapy 64(9) 609-614 https://doi.org/10.1016/j.biopha.2010.06.004 PMID: 20888174
23. Loehberg CR et al (2007) Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis Cancer Research 67(24) 12026-12033 https://doi.org/10.1158/0008-5472.CAN-07-3058 PMID: 18089834
24. Maclean KH et al (2008) Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis The Journal of Clinical Investigation 118(1) 79-88 https://doi.org/10.1172/JCI33700
25. Sun K et al (2013) Paradoxical role of autophagy in the dysplastic and tumor-forming stages of hepatocarcinoma development in rats Cell Death & Disease 4 e501 https://doi.org/10.1038/cddis.2013.35
26. Maes H et al (2014) Tumor vessel normalization by chloroquine independent of autophagy Cancer Cell 26(2) 190-206 https:// doi.org/10.1016/j.ccr.2014.06.025 PMID: 25117709
27. Yang S et al (2011) Pancreatic cancers require autophagy for tumor growth Genes and Development 25(7) 717-729 https://doi. org/10.1101/gad.2016111 PMID: 21406549 PMCID: 3070934
28. Maycotte P et al (2015) STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious Cancer Research 74(9) 2579-2590 https://doi.org/10.1158/0008-5472.CAN-13-3470
29. Hiraki K and Kimura I (1963) Studies on the treatment of malignant tumors with fibroblast-inhibiting agent. II. Effects of chloroquine on animal tumors Acta Medicinae Okayama 17 239-252 PMID: 14164121
30. Pellegrini P et al (2014) Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies Autophagy 10(4) 562-571 https://doi.org/10.4161/auto.27901 PMID: 24492472 PMCID: 3984580
31. Rouschop KMA et al (2010) The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 The Journal of Clinical Investigation 120(1) 127-141 https://doi.org/10.1172/JCI40027 PMCID: 2798689
32. Dutta P et al (1994) Enhanced growth of mammary adenocarcinoma in rats by chloroquine and quinacrine Cancer Letters 76 113-119 https://doi.org/10.1016/0304-3835(94)90386-7 PMID: 8149339
33. Yamaguchi I et al (1966) Influence of host conditions upon the growth pattern of transplanted tumors Tohoku Journal of Experimental Medicine 90 291-301 https://doi.org/10.1620/tjem.90.291 PMID: 5971610
34. Chi C et al (2010) Disruption of lysosome function promotes tumor growth and metastasis in drosophila The Journal of Biological Chemistry 285(28) 21817-21823 https://doi.org/10.1074/jbc.M110.131714 PMID: 20418542 PMCID: 2898421
35. Rosenfeldt MT et al (2013) P53 status determines the role of autophagy in pancreatic tumour development Nature 504(7479) 296-300 https://doi.org/10.1038/nature12865 PMID: 24305049
36. Jonckheere N et al (2014) Of autophagy and in vivo pancreatic carcinogenesis: the p53 status matters! Clinics and Research in Hepatology and Gastroenterology 38(4) 423-425 https://doi.org/10.1016/j.clinre.2014.04.009 PMID: 24939064
37. Keith CT et al (2005) Multicomponent therapeutics for networked systems Nature Reviews Drug Discovery 4(1) 71-78 https://doi. org/10.1038/nrd1609 PMID: 15688074
38. Briceño E et al (2003) Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine Neurosurgical Focus 14(2) e3 https://doi.org/10.3171/foc.2003.14.2.4
39. Sotelo J et al (2006) Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial Annals of Internal Medicine 144 337-343 https://doi.org/10.7326/0003-4819-144-5-200603070-00008 PMID: 16520474
40. Gilbert MR (2006) New treatments for malignant gliomas: careful evaluation and cautious optimism required Annals of Iinternal Medicine 144(5) 371-373 https://doi.org/10.7326/0003-4819-144-5-200603070-00015
41. Briceño E et al (2007) Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme Surgical Neurology 67(4) 388-391 https://doi.org/10.1016/j.surneu.2006.08.080 PMID: 17350410
42. Bilger A et al (2014) FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results Strahlentherapie und Onkologie 190(10) 957-961 https://doi.org/10.1007/s00066-014-0693-2 PMID: 24928248
43. Rojas-Puentes LL et al (2013) Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases Radiation Oncology (London, England) 8 209 https://doi.org/10.1186/1748-717X-8-209
44. Eldredge HB et al (2013) Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial Journal of Radiation Oncology 2(3) 315-321 https://doi.org/10.1007/s13566-013-0111-x
45. Munshi A et al (2008) Unusual intensification of skin reactions by chloroquine use during breast radiotherapy Acta Oncologica (Stockholm, Sweden) 47(2) 318-319 https://doi.org/10.1080/02841860701491058
46. Rustogi A et al (2006) Unexpected skin reaction induced by radiotherapy after chloroquine use The Lancet. Oncology 7(7) 608-609 https://doi.org/10.1016/S1470-2045(06)70763-X PMID: 16814214
47. Levy JMM et al (2014) Autophagy inhibition improves chemosensitivity in BRAFV600E brain tumors Cancer Discovery 4(7) 773-780 https://doi.org/10.1158/2159-8290.CD-14-0049 PMID: 24823863 PMCID: 4090283
48. Mulcahy Levy JM et al (2017) Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors eLife 6 358-367 https://doi.org/10.7554/eLife.19671
49. Montanari F et al (2014) A phase II trial of chloroquine in combination with bortezomib and cyclophosphamide in patients with relapsed and refractory multiple myeloma Blood 124(21) 5775
50. Kyle RA et al (1975) Multiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208) Cancer Chemotherapy Reports. Part 1 59(3) 557-562 PMID: 1203882
51. Rangwala R et al (2014) Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma Autophagy 10(8) 1391-1402 https://doi.org/10.4161/auto.29119 PMID: 24991838 PMCID: 4203516
52. Rangwala R et al (2014) Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma Autophagy 10(8) 1369-1379 https://doi.org/10.4161/auto.29118 PMID: 24991839 PMCID: 4203514
53. Mahalingam D et al (2014) Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors Autophagy 10(8) 1403-1414 https://doi.org/10.4161/auto.29231 PMID: 24991835 PMCID: 4203517
54. Chi K-H et al (2015) Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort Oncotarget 6(18) 16735-16745 https://doi.org/10.18632/oncotarget.3793 PMID: 25944689 PMCID: 4599303
55. Rosenfeld MR et al (2014) A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme Autophagy 10(8) 1359-1368 https://doi. org/10.4161/auto.28984 PMID: 24991840 PMCID: 4203513
56. Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma The New England Journal of Medicine 352(10) 987-996 https://doi.org/10.1056/NEJMoa043330 PMID: 15758009
57. Goldberg SB et al (2012) A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer Journal of Thoracic Oncology 7(10) 1602-1608 https://doi.org/10.1097/JTO.0b013e318262de4a PMID: 22878749 PMCID: 3791327
58. Leung L-SB et al (2015) Rapid onset of retinal toxicity from high-dose hydroxychloroquine given for cancer therapy American Journal of Ophthalmology 160(4) 799.e1-805.e1 https://doi.org/10.1016/j.ajo.2015.07.012
59. Vogl DT et al (2014) Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma Autophagy 10(8) 1380-1390 https://doi.org/10.4161/auto.29264 PMID: 24991834 PMCID: 4203515
60. Boone BA et al (2015) Safety and biologic response of pre-operative autophagy inhibition in combination with gemcitabine in patients with pancreatic adenocarcinoma Annals of Surgical Oncology 22(13) 4402-4410 https://doi.org/10.1245/s10434-015- 4566-4 PMID: 25905586 PMCID: 4663459
61. Wolpin BM et al (2014) Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma The Oncologist 19(6) 637-638 https://doi.org/10.1634/theoncologist.2014-0086 PMID: 24821822 PMCID: 4041680
62. Chi M-S et al (2015) Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients Oncotarget 6(30) 29808-29817 https://doi.org/10.18632/oncotarget.5060 PMID: 26375670 PMCID: 4745764
63. Glick D et al (2010) Autophagy: cellular and molecular mechanisms The Journal of Pathology 221(1) 3-12 https://doi.org/10.1002/ path.2697 PMID: 20225336 PMCID: 2990190
64. Sehgal A et al (2014) You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia Leukemia 29(3) 517-525 https://doi.org/10.1038/leu.2014.349 PMID: 25541151 PMCID: 4825874
65. Parzych KR and Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation Antioxidants & Redox Signaling 20(3) 460-473 https://doi.org/10.1089/ars.2013.5371
66. Viry E et al (2014) Autophagy: an adaptive metabolic response to stress shaping the antitumor immunity Biochemical Pharmacology 92(1) 1-12 https://doi.org/10.1016/j.bcp.2014.07.006
67. Cicchini M et al (2015) Molecular pathways: autophagy in cancer-a matter of timing and context Clinical Cancer Research 21(3) 498-504 https://doi.org/10.1158/1078-0432.CCR-13-2438
68. Cheong H (2015) Integrating autophagy and metabolism in cancer Archives of Pharmacal Research 38(3) 358-371 https://doi. org/10.1007/s12272-015-0562-2 PMID: 25614051
69. Janku F et al (2011) Autophagy as a target for anticancer therapy Nature Reviews Clinical Oncology 8(9) 528-539 https://doi. org/10.1038/nrclinonc.2011.71 PMID: 21587219
70. Rebecca VW and Amaravadi RK (2016) Emerging strategies to effectively target autophagy in cancer Oncogene 35(1) 1-11 https://doi.org/10.1038/onc.2015.99 PMCID: 4838040
71. Townsend KN et al (2012) Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity Immunological Reviews 249(1) 176-194 https://doi.org/10.1111/j.1600-065X.2012.01141.x PMID: 22889222
72. Loehberg CR et al (2012) Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001 Biochemical Pharmacology 83(4) 480-488 https://doi.org/10.1016/j.bcp.2011.11.022
73. Zhang Y et al (2014) Functional expression of TLR9 in esophageal cancer Oncology Reports 31(5) 2298-2304. https://doi. org/10.3892/or.2014.3095 PMID: 24647486
74. Zhang Y et al (2015) Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9/nuclear factor kappa B signaling pathway Molecular Medicine Reports 11(2) 1366-1371 https://doi.org/10.3892/mmr.2014.2839
75. Väisänen MR et al (2013) Expression of toll-like receptor-9 is associated with poor progression-free survival in prostate cancer Oncology Letters 5(12) 1659-1663 PMID: 23761830 PMCID: 3678868
76. Mohamed FE et al (2015) Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma Liver International 35(3) 1063-1076 https://doi.org/10.1111/liv.12626
77. Kuznik A et al (2011) Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines The Journal of Immunology 186(8) 4794-4804 https://doi.org/10.4049/jimmunol.1000702 PMID: 21398612
78. Sandholm J et al (2014) Hypoxia regulates toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro Oncology Letters 8 266-274 PMID: 24959259 PMCID: 4063648
79. Tuomela J et al (2012) Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer Breast Cancer Research and Treatment 135 481-493 https://doi.org/10.1007/s10549-012-2181-7 PMID: 22847512
80. Tuomela J et al (2013) Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer Oncol ogy Letters 6 1665-1672 PMID: 24273604 PMCID: 3835157
81. Sun X et al (2010) CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression Cancer Metastasis Reviews 29(4) 709-722 https://doi.org/10.1007/s10555-010-9256-x PMID: 20839032 PMCID: 3175097
82. Kim J et al (2012) Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells PloS One 7(2) e31004 https://doi.org/10.1371/journal.pone.0031004 PMID: 22319600 PMCID: 3272047
83. Balic A et al (2014) Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling Molecular Cancer Therapeutics 13(7) 1758-1771 https://doi.org/10.1158/1535-7163.MCT-13-0948 PMID: 24785258
84. Bieging KT et al (2014) Unravelling mechanisms of p53-mediated tumour suppression Nature Reviews Cancer 14(5) 359-370 https://doi.org/10.1038/nrc3711 PMID: 24739573 PMCID: 4049238
85. Zhou Q et al (2002) Control of mammary tumor cell growth in vitro by novel cell differentiation and apoptosis agents Breast Cancer Research and Treatment 75(2) 107-117 https://doi.org/10.1023/A:1019698807564 PMID: 12243503
86. Lee SW et al (2015) The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells Cancer Letters 360(2) 195-204 https://doi.org/10.1016/j.canlet.2015.02.012 PMID: 25681668
87. Amaravadi R and Debnath J (2014) Mouse models address key concerns regarding autophagy inhibition in cancer therapy Cancer Discovery 4(8) 873-875 https://doi.org/10.1158/2159-8290.CD-14-0618 PMID: 25092744 PMCID: 4124512
88. Yang A and Kimmelman AC (2014) Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status Autophagy 10(9) 1683-1684 https://doi.org/10.4161/auto.29961 PMID: 25046107 PMCID: 4206544
89. Liu F et al (2014) Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro Acta Pharmacologica Sinica 35(5) 645-652 https://doi.org/10.1038/aps.2014.3 PMID: 24727941 PMCID: 4814038
90. Geng Y et al (2010) Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent Neuro-Oncology 12(5) 473-481 PMID: 20406898 PMCID: 2940627
91. Burikhanov R et al (2017) Chloroquine-inducible par-4 secretion is essential for tumor cell apoptosis and inhibition of metastasis Cell Reports 18(2) 508-519 https://doi.org/10.1016/j.celrep.2016.12.051 PMID: 28076793 PMCID: 5264245
92. Amaravadi RK (2013) PUMA: a puzzle piece in chloroquine's antimelanoma activity The Journal of Investigative Dermatology 133(9) 2133-2135 https://doi.org/10.1038/jid.2013.135 PMID: 23949767 PMCID: 4825873
93. Jin L et al (2016) Glutaminolysis as a target for cancer therapy Oncogene 35(28) 3619-3625 https://doi.org/10.1038/onc.2015.447
94. Choi M-M et al (2007) Inhibitory properties of nerve-specific human glutamate dehydrogenase isozyme by chloroquine Journal of Biochemistry and Molecular Biology 40(6) 1077-1082 PMID: 18047806
95. Jarzyna R et al (1997) Chloroquine is a potent inhibitor of glutamate dehydrogenase in liver and kidney-cortex of rabbit Pharmacological Research : The Official Journal of the Italian Pharmacological Society 35(1) 79-84 https://doi.org/10.1006/phrs.1996.0108
96. Jarzyna R et al (2001) The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action European Journal of Pharmacology 428(3) 381-388 https://doi.org/10.1016/S0014-2999(01)01221-3 PMID: 11689198
97. Molenaar RJ et al (2017) Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1- mutated or IDH2-mutated solid tumours BMJ Open 7(6) e014961 https://doi.org/10.1136/bmjopen-2016-014961 PMID: 28601826 PMCID: 5541450
98. Lagneaux L et al (2001) Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factors British Journal of Haematology 112(2) 344-352 https://doi.org/10.1046/ j.1365-2141.2001.02553.x PMID: 11167827
99. Lagneaux L et al (2002) Hydroxychloroquine-induced apoptosis of chronic lymphocytic leukemia involves activation of caspase- 3 and modulation of Bcl-2/bax/ratio Leukemia & Lymphoma 43(5) 1087-1095 https://doi.org/10.1080/10428190290021506
100. Park BC et al (2008) Chloroquine-induced nitric oxide increase and cell death is dependent on cellular GSH depletion in A172 human glioblastoma cells Toxicology Letters 178(1) 52-60 https://doi.org/10.1016/j.toxlet.2008.02.003 PMID: 18359172
101. Jiang P et al (2008) Cell growth inhibition, G2/M cell cycle arrest, and apoptosis induced by chloroquine in human breast cancer cell line Bcap-37 Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 22(5-6) 431-440 https://doi.org/10.1159/000185488 PMID: 19088425
102. Fan C et al (2006) Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells Bioorganic & Medicinal Chemistry 14(9) 3218-3222 https://doi.org/10.1016/j.bmc.2005.12.035
103. Rahim R and Strobl JS (2009) Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells Anti-Cancer Drugs 20(8) 736-745 https://doi.org/10.1097/CAD.0b013e32832f4e50 PMID: 19584707
104. Justilien V and Fields AP (2015) Molecular pathways: novel approaches for improved therapeutic targeting of hedgehog signaling in cancer stem cells Clinical Cancer Research 21 505-513 https://doi.org/10.1158/1078-0432.CCR-14-0507 PMID: 25646180 PMCID: 4316382
105. Thongchot S et al (2015) Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells Asian Pacific Journal of Cancer Prevention : APJCP 16(5) 2031-2035 https://doi.org/10.7314/APJCP.2015.16.5.2031 PMID: 25773848
106. Choi DS et al (2014) Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1 Stem Cells (Dayton, Ohio) 32(9) 2309-2323 https://doi.org/10.1002/stem.1746
107. Liang DH et al (2016) The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair Cancer Letters 376(2) 249-258 https://doi.org/10.1016/j.canlet. 2016.04.002 PMID: 27060208 PMCID: 4864217
108. Inoue S et al (1993) Antimelanoma activity of chloroquine, an antimalarial agent with high affinity for melanin Pigment Cell Research / Sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society, 6(5), pp. 354-8. https://doi.org/10.1111/j.1600-0749.1993.tb00613.x PMID: 8302774
109. Karmali RA et al (1978) Chloroquine enhances Epstein-Barr virus expression Nature 275(5679) 444-445 https://doi. org/10.1038/275444a0 PMID: 211434
110. Lenoir G and Geser A (1979) Effect of chloroquine on Epstein-Barr virus expression Nature 282(5740) 758 https://doi. org/10.1038/282758b0 PMID: 229421
111. Mellman I et al (2011) Cancer immunotherapy comes of age Nature 480(7378) 480-489 https://doi.org/10.1038/nature10673 PMID: 22193102 PMCID: 3967235
112. Pascolo S (2016) Time to use a dose of chloroquine as an adjuvant to anti-cancer chemotherapies European Journal of Pharmacology 771 139-144 https://doi.org/10.1016/j.ejphar.2015.12.017
113. Bergers G and Benjamin LE (2003) Angiogenesis: tumorigenesis and the angiogenic switch Nature Reviews Cancer 3(6) 401-410 https://doi.org/10.1038/nrc1093 PMID: 12778130
114. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science (New York, NY) 307(5706) 58-62 https://doi.org/10.1126/science.1104819
115. Carmeliet P and Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases Nature Reviews Drug Discovery 10(6) 417-427 https://doi.org/10.1038/nrd3455 PMID: 21629292
116. Maes H et al (2014) How to teach an old dog new tricks: autophagy-independent action of chloroquine on the tumor vasculature Autophagy 10(11) 2082-2084 https://doi.org/10.4161/auto.36259 PMID: 25484095 PMCID: 4502691
117. Hagihara N et al (2000) Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107 advances in brief vascular protection by chloroquine during brain tumor therapy with Tf-CRM107 Cancer Research 60(2) 230-234 PMID: 10667564
118. McAllister SS and Weinberg RA (2014) The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis Nature Cell Biology 16(8) 717-727 https://doi.org/10.1038/ncb3015 PMID: 25082194
119. Ko Y-H et al (2011) Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance Cancer Biology & Therapy 12(12) 1085-1097 https://doi.org/10.4161/cbt.12.12.18671
120. Martinez-Outschoorn UE et al (2010) Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors Cell Cycle (Georgetown, TX) 9(12) 2423-2433 https://doi.org/10.4161/cc.9.12.12048
121. Kimura T et al (2013) Chloroquine in cancer therapy: a double-edged sword of autophagy Cancer Research 73(1) 3-7 https://doi. org/10.1158/0008-5472.CAN-12-2464 PMID: 23288916
122. Lee CM and Tannock IF (2006) Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration British Journal of Cancer 94(6) 863-869 https://doi.org/10.1038/sj.bjc.6603010 PMID: 16495919 PMCID: 2361369
123. Hurwitz SJ et al (1997) Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes Blood 89(10) 3745-3754 PMID: 9160680
124. Maycotte P et al (2012) Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy Autophagy 8(2) 200-212 https://doi.org/10.4161/auto.8.2.18554 PMID: 22252008 PMCID: 3336076
125. Vezmar M and Georges E (1998) Direct binding of chloroquine to the multidrug resistance protein (MRP): possible role for MRP in chloroquine drug transport and resistance in tumor cells Biochemical Pharmacology 56(6) 733-742 https://doi.org/10.1016/ S0006-2952(98)00217-2 PMID: 9751078
126. Vezmar M and Georges E (2000) Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs Biochemical Pharmacology 59(10) 1245-1252 https://doi.org/10.1016/S0006-2952(00)00270-7 PMID: 10736425
127. Maes H et al (2014) Dynamic interplay between autophagic flux and Akt during melanoma progression in vitro Experimental Dermatology 23(2) 101-106 https://doi.org/10.1111/exd.12298
128. Battisti S et al (2012) Nutritional stress and arginine auxotrophy confer high sensitivity to chloroquine toxicity in mesothelioma cells American Journal of Respiratory Cell and Molecular Biology 46(4) 498-506 https://doi.org/10.1165/rcmb.2011-0195OC
129. Amaravadi RK et al (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma The Journal of Clinical Investigation 117(2) 326-336 https://doi.org/10.1172/JCI28833 PMID: 17235397 PMCID: 1765515
130. Levy JM et al (2014) Using BRAF(V600E) as a marker of autophagy dependence in pediatric brain tumors Autophagy 10(11) 2077-2078 https://doi.org/10.4161/auto.36138
131. Egger ME et al (2013) Inhibition of autophagy with chloroquine is effective in melanoma The Journal of Surgical Research 184(1) 274-281 https://doi.org/10.1016/j.jss.2013.04.055 PMID: 23706562
132. Pimkina J and Murphy ME (2009) ARF, autophagy and tumor suppression Autophagy 5(3) 397-399 https://doi.org/10.4161/ auto.5.3.7782 PMID: 19221462 PMCID: 2667648
133. Mancias JD and Kimmelman AC (2011) Targeting autophagy addiction in cancer Oncotarget 2(12) 1302-1306 https://doi. org/10.18632/oncotarget.384 PMID: 22185891 PMCID: 3282086
134. Morgan MJ et al (2014) Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent Autophagy 10(10) 1814-1826 https://doi.org/10.4161/auto.32135 PMID: 25136801 PMCID: 4198365
135. Eng CH et al (2016) Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy Proceedings of the National Academy of Sciences of the United States of America 113(1) 182-187 https://doi.org/10.1073/pnas.1515617113 PMCID: 4711870
136. Hong S-K et al (2013) Autophagy sensitivity of neuroendocrine lung tumor cells International Journal of Oncology 43(6) 2031- 2038 https://doi.org/10.3892/ijo.2013.2136 PMID: 24126619 PMCID: 3834067
137. Vessoni AT et al (2016) Chloroquine-induced glioma cells death is associated with mitochondrial membrane potential loss, but not oxidative stress Free Radical Biology and Medicine 90 91-100 https://doi.org/10.1016/j.freeradbiomed.2015.11.008
138. Pantziarka P et al (2014) The Repurposing Drugs in Oncology (ReDO) project Ecancer Medical Science 8 442 PMID: 25075216 PMCID: 4096030
139. Buch I et al (2016) Schedule-dependent synergy of chloroquine with chemotherapy for anti-cancer treatment Cancer Research and Oncology: Open Access 2(2)
140. Schroeder RL and Gerber JP (2014) Chloroquine and hydroxychloroquine binding to melanin: some possible consequences for pathologies Toxicology Reports 1 963-968 https://doi.org/10.1016/j.toxrep.2014.10.019 PMID: 28962308 PMCID: 5598414
141. Sundelin SP and Terman A (2002) Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 110(6) 481-489 https://doi. org/10.1034/j.1600-0463.2002.100606.x PMID: 12193209
142. McAfee Q et al (2012) Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency Proceedings of the National Academy of Sciences of the United States of America 109(21) 8253-8258 https://doi.org/10.1073/pnas.1118193109 PMID: 22566612 PMCID: 3361415
143. Solomon VR and Lee H (2009) Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies European Journal of Pharmacology 625(1-3) 220-233 https://doi.org/10.1016/j.ejphar.2009.06.063 PMID: 19836374
144. Zhang H et al (2008) Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives Biomedicine & Pharmacotherapy 62(2) 65-69 https://doi.org/10.1016/j.biopha.2007.04.007
145. Goodall ML et al (2014) Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib Autophagy 10(6) 1120-1136 https://doi.org/10.4161/auto.28594 PMID: 24879157 PMCID: 4091172
146. Dai J-P et al (2013) Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity PloS One 8(4) e61026 https://doi.org/10.1371/journal. pone.0061026 PMID: 23613775 PMCID: 3628889
147. Anighoro A et al (2014) Polypharmacology: challenges and opportunities in drug discovery Journal of Medicinal Chemistry 57(19) 7874-7887 https://doi.org/10.1021/jm5006463 PMID: 24946140
148. Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery Nature Chemical Biology 4(11) 682-690 https:// doi.org/10.1038/nchembio.118 PMID: 18936753
149. Reagan-Shaw S et al (2008) Dose translation from animal to human studies revisited FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 22(3) 659-661 https://doi.org/10.1096/fj.07-9574LSF
150. Golden EB et al (2014) Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy Neurosurgical Focus 37(6) E12 https://doi.org/10.3171/2014.9.FOCUS14504 PMID: 25434381
151. Zanotto-Filho A et al (2015) Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas Cancer Letters 358(2) 220-231 https://doi.org/10.1016/j.canlet.2014.12.044
152. Gaudin D et al (1971) The effect of DNA repair inhibitors on e response of tumors treated with x-ray and alkylating agents Proceedings of the Society for Experimental Biology and Medicine (New York, NY) 137(1) 202-206 https://doi.org/10.3181/00379727- 137-35544
153. Lefort S et al (2014) Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triplenegative breast cancers Autophagy 10(12) 2122-2142 https://doi.org/10.4161/15548627.2014.981788 PMID: 25427136 PMCID: 4502743
154. Yu L et al (2014) Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance Cancer Letters 355 34-45 https://doi.org/10.1016/j.canlet.2014.09.020 PMID: 25236911
155. Zhang H et al (2015) Antitumor activity of chloroquine in combination with cisplatin in human gastric cancer xenografts Asian Pacific Journal of Cancer Prevention 16 3907-3912 https://doi.org/10.7314/APJCP.2015.16.9.3907 PMID: 25987058
156. Zhao X et al (2015) Chloroquine-enhanced efficacy of cisplatin in the treatment of hypopharyngeal carcinoma in xenograft mice PloS One 10(4): e01 1-12
157. Ding Z-B et al (2011) Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 17(19) 6229-6238 https://doi.org/10.1158/1078-0432.CCR-11-0816 PMID: 21825039
158. Selvakumaran M et al (2013) Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy Clinical Cancer Research 19(11) 2995-3007 https://doi.org/10.1158/1078-0432.CCR-12-1542 PMID: 23461901
159. Shoemaker JP (1978) Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine Cancer Research 38(September) 2700-2702 PMID: 679173
160. Guo X-L et al (2012) Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells Cancer Letters 320(2) 171-179 https://doi.org/10.1016/j.canlet.2012.03.002 PMID: 22406827
161. Sasaki K et al (2012) Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study Anti-Cancer Drugs 23(7) 675-682 https://doi.org/10.1097/CAD.0b013e328353f8c7 PMID: 22561420
162. Shoemaker JP and Dagher RK (1979) Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate Journal of the National Cancer Institute 62(6) 1575-1578 PMID: 286128
163. Xiong S et al (2010) Triggering liposomal drug release with a lysosomotropic agent Journal of Pharmaceutical Sciences 99(12) 5011-5018 https://doi.org/10.1002/jps.22210 PMID: 20821395
164. Arnold AM and Whitehouse JM (1982) Interaction of VP16-213 with the DNA repair antagonist chloroquine Cancer Chemotherapy and Pharmacology 7(2-3) 123-126 https://doi.org/10.1007/BF00254533
165. Cook KL et al (2014) Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 20(12) 3222-3232 https://doi. org/10.1158/1078-0432.CCR-13-3227 PMID: 24928945 PMCID: 4073207
166. Seront E et al (2013) Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours British Journal of Cancer 109(10) 2597-2606 https://doi.org/10.1038/bjc.2013.644 PMID: 24157830 PMCID: 3833227
167. Bray K et al (2012) Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition PloS One 7(7) e41831 https://doi.org/10.1371/journal.pone.0041831 PMID: 22848625 PMCID: 3406086
168. Kaneko M et al (2014) Temsirolimus and chloroquine cooperatively exhibit a potent antitumor effect against colorectal cancer cells Journal of Cancer Research and Clinical Oncology 140(5) 769-781 https://doi.org/10.1007/s00432-014-1628-0 PMID: 24619662
169. Xie X et al (2013) Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma PloS One 8(1) e55096 https://doi.org/10.1371/journal.pone.0055096 PMID: 23383069 PMCID: 3559441
170. Rao R et al (2012) Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells Molecular Cancer Therapeutics 11(4) 973-983 https://doi.org/10.1158/1535-7163.MCT- 11-0979 PMID: 22367781
171. Carew JS et al (2010) Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation Journal of Cellular and Molecular Medicine 14(10) 2448-2459 https://doi.org/10.1111/j.1582-4934.2009.00832.x PMCID: 2891399
172. Ding W-X et al (2009) Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy Molecular Cancer Therapeutics 8(7) 2036-2045 https://doi.org/10.1158/1535-7163.MCT-08-1169 PMID: 19584239 PMCID: 2711219
173. Hui B et al (2012) Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma Cancer 118(22) 5560-5571 https://doi.org/10.1002/cncr.27586 PMID: 22517429
174. Tang M-C et al (2015) Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells PloS One 10(3) e0119135 https://doi.org/10.1371/journal.pone.0119135 PMID: 25807554 PMCID: 4373825
175. Dragowska WH et al (2013) Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer PLoS One 8(10) 1-20 https://doi.org/10.1371/journal.pone.0076503
176. Bokobza SM et al (2014) Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells Oncotarget 5(13) 4765-4778 https://doi.org/10.18632/oncotarget.2017 PMID: 24946858 PMCID: 4148097
177. Zou Y et al (2013) The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 8(6) 693-702 https://doi.org/10.1097/JTO.0b013e31828c7210 PMID: 23575415 PMCID: 3855301
178. Bellodi C et al. (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome- positive cells, including primary CML stem cells The Journal of Clinical Investigation 119(5) 1109-1123 https://doi. org/10.1172/JCI35660 PMID: 19363292 PMCID: 2673867
179. Abdel-Aziz AK et al (2014) Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries Chemico-Biological Interactions 217 28-40 https://doi.org/10.1016/j.cbi.2014.04.007 PMID: 24751611
180. Shimizu S et al (2012) Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma International Journal of Cancer 131(3) 548-557 https://doi.org/10.1002/ijc.26374
181. Shi Y-H et al (2011) Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis Autophagy 7(10) 1159-1172 https://doi.org/10.4161/auto.7.10.16818 PMID: 21691147
182. Ji C et al (2014) Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer Cancer Biology & Therapy 15(5) 570-577 https://doi.org/10.4161/cbt.28162
183. You L et al (2015) Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines Oncotarget 6(37) 40268-40282 https://doi.org/10.18632/oncotarget.5592 PMID: 26384345 PMCID: 4741894
184. Mitou G et al (2015) Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma Oncotarget 6(30) 30149-30164 https://doi.org/10.18632/oncotarget.4999 PMID: 26338968 PMCID: 4745787
185. Shen J et al (2013) Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma British Journal of Cancer 109(1) 164-171 https://doi.org/10.1038/bjc.2013.306 PMID: 23799852 PMCID: 3708568
186. Hu Y-L et al (2012) Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma Cancer Research 72(7) 1773-1783 https://doi.org/10.1158/0008-5472.CAN-11-3831 PMID: 22447568 PMCID: 3319869
187. Cufí S et al (2013) The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer Scientific Reports 3 2469 https://doi.org/10.1038/srep02469 PMCID: 3749547
188. Ratikan JA et al (2013) Chloroquine engages the immune system to eradicate irradiated breast tumors in mice International Journal of Radiation Oncology, Biology, Physics 87(4) 761-768 https://doi.org/10.1016/j.ijrobp.2013.07.024 PMID: 24138918
189. Wei M-F et al (2014) Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells Autophagy 10(7) 1179-1192 https://doi.org/10.4161/auto.28679 PMID: 24905352 PMCID: 4203546
190. Liang X et al (2012) Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression Cancer Research 72(11) 2791-2801 https://doi.org/10.1158/0008-5472.CAN-12-0320 PMID: 22472122 PMCID: 3417121
191. Thomas S et al (2012) Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors Cancer Letters 325(1) 63-71 https://doi. org/10.1016/j.canlet.2012.05.030 PMID: 22664238
192. Harhaji-Trajkovic L et al (2012) Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation Pharmaceutical Research 29(8) 2249-2263 https://doi.org/10.1007/s11095-012-0753-1 PMID: 22538436
193. Thomas R et al (1990) The effect of chloroquine and hyperthermia on murine neuroblastoma Journal of Pediatric Surgery 25(9) 929-932 https://doi.org/10.1016/0022-3468(90)90232-X PMID: 2213444
194. Gao L et al (2013) Chloroquine promotes the anticancer effect of TACE in a rabbit VX2 liver tumor model International Journal of Biological Sciences 9(4) 322-330 https://doi.org/10.7150/ijbs.5925 PMID: 23569437 PMCID: 3619094